Literature DB >> 21736987

Neuroblastoma.

Nadja C Colon1, Dai H Chung.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21736987      PMCID： PMC3668791          DOI： 10.1016/j.yapd.2011.03.011

Source DB:  PubMed          Journal:  Adv Pediatr        ISSN： 0065-3101


× No keyword cloud information.
  45 in total

Review 1.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

Review 2.  On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology.

Authors:  Carol J Thiele; Zhijie Li; Amy E McKee
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

3.  Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma.

Authors:  Tom Van Maerken; Frank Speleman; Joëlle Vermeulen; Irina Lambertz; Sarah De Clercq; Els De Smet; Nurten Yigit; Vicky Coppens; Jan Philippé; Anne De Paepe; Jean-Christophe Marine; Jo Vandesompele
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

4.  A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.

Authors:  Güllü Görgün; Elisabetta Calabrese; Teru Hideshima; Jeffrey Ecsedy; Giulia Perrone; Mala Mani; Hiroshi Ikeda; Giada Bianchi; Yiguo Hu; Diana Cirstea; Loredana Santo; Yu-Tzu Tai; Sabikun Nahar; Mei Zheng; Madhavi Bandi; Ruben D Carrasco; Noopur Raje; Nikhil Munshi; Paul Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2010-04-09       Impact factor: 22.113

Review 5.  Neuroblastoma: Therapeutic strategies for a clinical enigma.

Authors:  Shakeel Modak; Nai-Kong V Cheung
Journal:  Cancer Treat Rev       Date:  2010-03-12       Impact factor: 12.111

Review 6.  Recent advances in neuroblastoma.

Authors:  John M Maris
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

Review 7.  Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.

Authors:  Robert A Casero; Laurence J Marton
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

8.  Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

Authors:  Katherine K Matthay; Gregory Yanik; Julia Messina; Alekist Quach; John Huberty; Su-Chun Cheng; Janet Veatch; Robert Goldsby; Patricia Brophy; Leslie S Kersun; Randall A Hawkins; John M Maris
Journal:  J Clin Oncol       Date:  2007-03-20       Impact factor: 44.544

9.  Structure of the human mTOR complex I and its implications for rapamycin inhibition.

Authors:  Calvin K Yip; Kazuyoshi Murata; Thomas Walz; David M Sabatini; Seong A Kang
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

10.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117
View more
  47 in total

1.  Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.

Authors:  Raoud Marayati; Adele P Williams; Laura V Bownes; Colin H Quinn; Jerry E Stewart; Elizabeth Mroczek-Musulman; Venkatram R Atigadda; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2020-02-28       Impact factor: 2.545

2.  Delineation of the frequency and boundary of chromosomal copy number variations in paediatric neuroblastoma.

Authors:  Nicholas Ho; Hui Peng; Chelsea Mayoh; Pei Y Liu; Bernard Atmadibrata; Glenn M Marshall; Jinyan Li; Tao Liu
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

3.  Clinical Significance of Pretreatment FDG PET/CT in MIBG-Avid Pediatric Neuroblastoma.

Authors:  Seo Young Kang; Muhammad Kashif Rahim; Yong-Il Kim; Gi Jeong Cheon; Hyoung Jin Kang; Hee Young Shin; Keon Wook Kang; June-Key Chung; E Edmund Kim; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2016-10-06

4.  Exosomes: Novel Players of Therapy Resistance in Neuroblastoma.

Authors:  Heather Richard; Arya Pokhrel; Srinivas Chava; Anup Pathania; Santharam S Katta; Kishore B Challagundla
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Distribution of segmental chromosomal alterations in neuroblastoma.

Authors:  A Juan Ribelles; P Gargallo; C Ferriol; V Segura; Y Yáñez; B Juan; A J Cañada; J Font de Mora; A Cañete; V Castel
Journal:  Clin Transl Oncol       Date:  2020-09-18       Impact factor: 3.405

Review 6.  Renovascular hypertension in pediatric patients: update on diagnosis and management.

Authors:  Juliana Lacerda de Oliveira Campos; Letícia Bitencourt; Ana Luisa Pedrosa; Diego Ferreira Silva; Filipe Ji Jen Lin; Lucas Teixeira de Oliveira Dias; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2021-04-13       Impact factor: 3.714

Review 7.  Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation.

Authors:  Xiaoli He; Yongkang Liao; Jing Liu; Shuming Sun
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

8.  Nitroalkanes as electrophiles: synthesis of triazole-fused heterocycles with neuroblastoma differentiation activity.

Authors:  Nicolai A Aksenov; Alexander V Aksenov; Nikita K Kirilov; Nikolai A Arutiunov; Dmitrii A Aksenov; Vladimir Maslivetc; Zhenze Zhao; Liqin Du; Michael Rubin; Alexander Kornienko
Journal:  Org Biomol Chem       Date:  2020-08-19       Impact factor: 3.876

9.  Preclinical In Vitro Studies with 3D Spheroids to Evaluate Cu(DDC)2 Containing Liposomes for the Treatment of Neuroblastoma.

Authors:  Friederike Hartwig; Monika Köll-Weber; Regine Süss
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

10.  Comparison Between Diffusion-Weighted MRI and 123 I-mIBG Uptake in Primary High-Risk Neuroblastoma.

Authors:  Laura Privitera; Patrick W Hales; Layla Musleh; Elizabeth Morris; Natalie Sizer; Giuseppe Barone; Paul Humphries; Kate Cross; Lorenzo Biassoni; Stefano Giuliani
Journal:  J Magn Reson Imaging       Date:  2020-12-06       Impact factor: 5.119
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.